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Abstract : Integrins are responsible for anchoring cells to the extracellular matrix and also can initiate
intracellular signal pathways. The interaction between integrins and the extracellular matrix results
in activation of PKC, PTKs, p21Ras, MAPK and PI3-kinase. The α4β1 integrins are expressed mainly
on haematopoietic cells and also appear on several tumour types. The adhesion of α4β1 to VCAM-1
is an essential step for lymphocyte extravasation during the inflammatory response. Furthermore,
the interaction of α4β1, expressed on tumour cells, with VCAM-1, might have a role in tumour cell
extravasation.
We examined the role of PI3-kinase activation in α4β1-mediated melanoma cell adhesion and
migration. Inhibition of PI3-kinase did not have any effect on cell adhesion. However, the migration
of HMB2-α4 and DX3 cells on fibronectin, but not VUP-α4, was inhibited by PI3-kinase inhibitor.
αvβ3-mediated migration in VUP cells which had been transfected with β3 cDNA to create expression
of the αvβ3, did not involve PI3-kinase activity, suggesting that this was not the case. On the other
hand, VUP-α4 cells were found not to express p110α, a specific form of PI3-kinase, which may be
involved in melanoma migration, whereas the HMB2-α4 cells expressed this isoform.
Key Words: integrin, PI3-kinase, migration, melanoma, adhesion

P13-Kinaz’›n Melanoma Hücre Ba¤lanmas› ve Göçündeki Rolü
Özet : ‹ntegrinler hücreler aras› proteinlere ba¤lanmalar›n›n yan›s›ra hücre içi sinyal yollar›n› da aktive
etme yetene¤ine sahiptirler. ‹ntegrinlerin extrasellüler proteinler ile etkileflmesi sonucu protein kinaz
C, protein tyrozin kinaz, p21ras, MAPK ve PI3-kinaz gibi sinyal moleküllerinin aktivasyonu mümkün
olmaktad›r. α4β1 integrini ço¤unlukla kan hücrelerinde bulunmaktad›r bunun yan›nda birkaç çeflit
tumor hücresinde de varl›¤› tespit edilmifltir. Dokularda oluflan hasar›n tamiri s›ras›nda lökositlerin
hasarl› dokuya geçiflindeki en önemli basamaklardan bir tanesi α4β1-VCAM-1 iliflkisidir. Bu iliflkiyi
kullanan tumor hücrelerinin de kan damarlar›ndan dokulara geçti¤i düflünülmektedir.
Bu çal›flmada PI3-kinaz moleküllünün melanoma hücrelerinin ba¤lanma ve göç yeteneklerine olan
etkileri araflt›r›lm›flt›r. PI3-kinaz›n bask›lanmas› hücre ba¤lanmas›n› etkilememifltir. Fakat, HMB2-α4
ve DX3 melanoma hücrelerinin fibronektin üzerindeki göçü PI3-kinaz inhibitörü taraf›ndan bloke
edilmifltir. PI3-kinaz inaktivasyonu VUP-α4 hücrelerinin göçünde ise etkili olmam›flt›r. αvβ3 integrini
transfer edilmifl VUP hücreleriyle yap›lan deneyler ise bu integrininde etkili olmad›¤›n› göstermifltir.
Di¤er bir yandan, VUP-α4 hücrelerinde p110α’in bulunmad›¤› tespit edilmifl ve melanoma hücre
göçünde bu formun etkili olabilece¤i fikrine var›lm›flt›r.
Anahtar Sözcükler: integrin, PI3-kinaz, göç, hücre ba¤lanmas›
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Introduction
Integrins are a major family of cell surface receptors composed of heterodimers, α and β
subunits, that are responsible for anchoring cells to the extracellular matrix (ECM). They also
can interact with cellular signal transduction molecules and transmit signals to the nucleus
following stimulation received from interaction with the ECM (1,2). Integrin signalling
regulates various important events during embryogenesis and development, normal cell
proliferation, differentiation, migration and survival and, in cancer cells, uncontrolled cell
growth and metastasis (3). The signals generated by integrin-ECM interactions result in the
activation of a number of signal pathways, including inositol lipid synthesis (4), activation of
protein kinases (5), PKC pathways (6) and changes in intracellular pH and Ca2+ levels (7,8).
Recently, the integrin-mediated activation of mitogen-activated protein kinase (MAPK),
phosphatidylinositol 3-kinase (PI3-kinase) and p21Ras (9,10,11) have also been demonstrated,
firmly linking the adhesive mechanisms of the cell with its proliferation machinery.
The α4β1 integrins, which are members of the integrin family, are particularly interesting
due to their involvement in various developmental and physiological processes (12). Two α4
integrins, α4β1 and α4β7, interact with an alternative-spliced segment of fibronectin (V25 or
CS1) and with the counter-receptors, VCAM-1 and MAdCAM-1. The α4 integrins are suggested
to have a role in haematopoiesis, lymphoid and myeloid cells, lymphocyte homing and
metastasis (13,14,15). The α4β1 integrin is expressed primarily on various leukocytes such as
normal peripheral blood B and T cells and monocytes, but not on neutrophils (16), and also α4
integrin may appear on some nonhaematopoietic cells such as muscle cells and nervous system
cells (17). Several tumour types other than melanoma have also been shown to express α4β1,
including neuroblastoma, renal cell, rhabdomyosarcoma and osteosarcoma (18,19,20).
In this paper, our aim is to describe the effect of PI3-kinase on α4β1-mediated melanoma
cell migration and adhesion. PI3-kinase is composed of 110 and 85kDa subunits (21) and the
p110 subunit of PI3-kinase has been shown to be a catalytic domain of this enzyme containing
the lipid kinase activity (22,23). The p85 subunit is a regulatory domain which has many
sequence similarities to the protein-protein interaction domains known to occur in other
signalling enzymes. The p85 subunit contains two SH2 domains, a SH3 domain and a break
point cluster region (BCR) domain. Members of the PI3-kinase family showed high homology
in the lipid kinase domain and the catalytic domain but the p110γ PI3-kinase form was shown
to lack the p85 binding domain.
Some reports have suggested that PI3-kinase is involved in integrin-mediated signal
transduction cascades as well as in regulating integrin-mediated cellular events, such as cell
migration (24) and adhesion (25). Platelet aggregation, induced by thrombin or activating
peptides, is mediated by activated αIIbβ3 integrin and can be inhibited by blocking PI3-kinase
activity with specific inhibitors such as Wortmannin (26). Wortmannin was also shown to inhibit
β1 integrin-mediated adhesiveness following stimulation of the CD7 antigen on T cells. In
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neutrophils, β2-mediated adhesion stimulates PI3-kinase activity (25) and, in osteoclasts,
αvβ3-mediated adhesion stimulates activation and association of PI3-kinase with c-Src (27). In
human melanoma cells, migration on fibronectin, αvβ3 integrin-mediated adhesion on
vitronectin and actin stress fibre formation were also inhibited by Wortmannin in a dosedependent manner (28), while a possible role for PKC also has been described in experiments
on PI3-kinase induced cell motility (24).

Materials and Methods
Cell Lines and Cell Culture
Various human melanoma cell lines were used in this study; HMB2, α4-expressing HMB2α4 and DX3 human malignant melanoma cell lines are cutaneous melanoma lines, originally
derived from metastases. In addition, VUP, which is an ocular melanoma line derived from a
primary choroidal tumour and α4-expressing derivative VUP-α4 were also used.
The cells were cultured in sterile plastic tissue culture flasks in E4 medium supplemented
with 10% (v/v) heat inactivated foetal calf serum (GIBCO BRL Paisley, Scotland) and Lglutamine (1mM final concentration) as adherent monolayers. Melanoma cells were incubated
at 37ºC in 8% CO2/92% air in the humidified atmosphere provided by an incubator.
Antibodies
The monoclonal antibodies which were used here are as follows: anti-α4, 7.2 antibody, the
function of which is unknown (Marshall et al., unpublished; produced in-house); anti-α4, HP2/1
blocking antibody (Dr. F. Sanchez-Madrid); anti-α5, P1D6 blocking antibody (Life
Technologies, UK); anti-αvβ3, LM609 blocking antibody (Chemicon International, UK); anti-αv,
17E6 blocking antibody (29, E. Merk, Germany); anti-α3, P1B5 blocking antibody (Life
Technologies, UK).
Synthesis of Purified Substrates
CS1 Peptide
The α4β1 binding site in the alternatively spliced type III connecting segment of fibronectin
is a 24-amino acid sequence (CDELPQLVTLPHPNLHGPEILDVPST) called CS1 peptide that was
synthesised by the Peptide Synthesis Laboratories under the direction of Dr. Gerard Evan at
ICRF Lincoln’s Inn Fields, London. Amino acids shown in bold represent the minimal sequence
required for cell binding.
rs VCAM-1
Pure recombinant soluble VCAM-1 was supplied by British Biotechnology Ltd., Abingdon,
Oxford, UK.
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Adhesion Assay
Human melanoma cells were cultured as detailed previously. Cell adhesion assays were
performed in 96-well plates (Falcon 3912; Beckton Dickinson). Wells were coated for 60 min
at 37ºC with 50µl aliquots of various concentrations of human fibronectin, (Sigma Chemicals
Ltd., Poole, UK), vascular cell adhesion molecule (rsVCAM-1 British Biotech., UK) or CS1
peptide diluted with Dulbecco’s PBS. Any potential nonspecific cell adhesion sites were blocked
for 1h at 37ºC with 100µl of 0.1% (w/v) heat-denatured BSA in PBS. The cells were detached
51
with 0.25% trypsin/EDTA, resuspended in 400µl complete medium containing 0.37MBq [ Cr]
and incubated for 45 min at 37ºC. After the incubation time, the cells were washed three times
with Tris-buffered saline (TBS) pH 7.4 (-24mMTris/HCL, 137mM-NaCl, 2.7mM-KCl,
0.1%BSA, 2mM-Glucose) and resuspended to a final density of 3x105 cell/ml in Tris buffer. Cell
suspensions containing 1.5x104 cells treated with or without PI3-kinase inhibitor (LY294002)
were added to each well of the 96-well plates and allowed to attach to the substrata for 60
min at 37ºC in an incubator. Non-adherent cells were removed by rinsing the plates in a bath
of TBS (supplemented with 1mM-CaCl2 and 0.5mM-MgCl2). After two washes, the 96-well
plates were cut into individual wells and the radioactivity associated with each well TS
determined in a gamma counter (1261 Multigamma; LKB Wallac, Bromma, Sweden). The
percentage of adherent cells was determined by a comparison of the residual radioactivity with
the total input.
Migration Assay
Cell migration assays were performed using Transwell chambers (Costar, UK) containing
8µm-diameter pore size polycarbonate membranes. The undersurface of the membrane was
coated by incubation with a 200µl volume of various extracellular matrix proteins (10µg/ml of
Fn, 20µg/ml of VCAM-1, 50µg/ml of CS1) for 1h at 37ºC and then the substrate solution was
discarded and inserts were washed twice with sterile PBSA. After a final wash, PBSA was
replaced with 0.1% (w/v) BSA in PBSA to block non-specific binding and the wells were
incubated for 30 min to 1h at 37ºC. While the plates were in the incubator, cells were harvested
with 0.25% trypsin/EDTA and washed three times with E4 containing 0.5% heat-denatured
BSA. The same medium was also placed in the lower chamber. Cells (1x105/100µl) treated with
or without LY294002 in the assay medium were added to the upper chamber and incubated at
37ºC for 24h. The cells in both the upper and the lower chambers were detached with 0.25%
trypsin/EDTA and counted on a CASY-II cell analyser (Scharfe System, Germany). The total cell
number was determined and the percentage of migration was calculated.
Inhibition of Migration Assay
The cells were incubated with various antibodies (HP2/1 (anti-α4, 10µg/ml), 17E6 (antiαv, 2µg/ml), P1D6 (anti-α5, 1:50)) on ice for 20 min and then washed three times with 0.5%
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BSA in E4. After the last wash, the cells were resuspended in assay medium and 100µl of cells
and antibody complex were placed into the upper chamber of a transwell insert. Similar
concentrations of antibodies were added into the lower chamber and the migration assay was
carried out as described above.
Flow Cytometry
The expression of integrins was assayed by indirect immunofluorescence using a flow
cytometric technique. Melanoma cells were harvested with 0.25% trypsin/EDTA, resuspended
in complete medium and washed twice with cell wash buffer (0.1% BSA, 0.1% Azide in PBSA).
Cell suspensions containing 2x105 cells/50µl were added to each well of 96-well plates and 50µl
of control or experimental antibodies were also added to each well. After a 30 min incubation
at 4ºC, cells were washed three times with cold wash buffer and resuspended in wash buffer
containing FITC-RAM (DAKO). After another 30 min incubation at 4ºC, cells were washed with
wash buffer four times and resuspended in 10% (v/v) formaldehyde in PBSA. Those
preparations analysed the next day were kept at 4ºC overnight. Cells were resuspended into
400µl of PBSA and analysed with a flow cytometer (FACScan; Becton Dickinson) using Consort
30 software.
MTT Dye Reduction Assay
Monolayer HMB2-α4 and VUP-α4 melanoma cells in exponential growth phase were
harvested and incubated with various dilutions of LY294002 (Calbiochem, UK) for 1h at 37ºC.
The excess drug was washed off with culture medium, a single cell suspension was prepared
and the cell number determined using a haemocytometer. Samples were resuspended in fresh
4
4
medium to give a density of 2.5x10 /ml for HMB2-α4 and 5x10 /ml for VUP-α4 cells. Aliquots
(200µl) of the cell suspensions were placed into each of 88 wells of a 96-well microtitre plate.
The initial row of 8 wells was filled with 200µl of medium alone to serve as a blank. Plates
were then incubated in an 8% CO2 atmosphere at 37ºC. The number of living cells was
measured each day. At the end of the exposure time, 20µl of MTT dye solution (5mg/ml in
sterile PBSA) was added to each well and the plates were incubated for a further 2 h. The
medium containing MTT solution was then gently removed from the wells by aspiration leaving
the reduced tetrazolium salt present as blue crystals in the wells. The tetrazolium salt was then
solubilised by addition of 200µl of DMSO to each well, followed by agitation using a plate
shaker for 10 min. Absorbance at 540 nm was determined by use of a Dynatech. MR5000
(Dynatech Lab, USA) plate reader with a reference beam of 690nm. Values obtained for the
medium blanks automatically were subtracted. Each drug concentration was repeated 4 times
per experiment. The results of repeat wells within the same experiment were averaged and the
SD within each experiment was always <10%.
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Results
Effect of PI3-kinase on Melanoma Cell Adhesion and Migration
The consequence of PI3-kinase inhibition on melanoma cell adhesion and migration was
investigated by using the specific PI3-kinase inhibitor LY294002. The effect of this agent,
which inhibits ATP-binding activity of PI3-kinase, is shown in Figure 1. Basically the treatment
of VUP-α4 cells with this inhibitor at concentrations ranging from 5 to 10µg/ml had no effect
upon either adhesion or migration, on a range of substrates.
In contrast, substantial effects on one of these characteristics were obtained when HMB2α4 cells were used in similar experiments. Thus, as shown in Figure 2, panel A, there was no
effect of LY294002 on cell adhesion but, as documented in Figure 2, panel B, there was a
substantial reduction in the migration of these cells on a fibronectin substrate. This meant that
at a concentration of 10µg/ml, the migratory capacity of these cells was reduced by about 75%
on this substrate. Interestingly there was no significant effect of equal doses in the migratory
capacity on VCAM-1 (Figure 2, panel B). Experiments using an additional melanoma line known
to express α4 at its surface (DX3) gave similar though less dramatic results (Figure 3). The
Figure 1.
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Effect of PI3-kinase inhibition
on α4β1-mediated adhesion
(A) and migration (B) in VUPα4 melanoma cells. 510µg/ml LY294002 was
added to cells (A) that were
plated out onto 96-well plates
coated
with
10µg/ml
Fibronectin, 20µg/ml CS1 and
10µg/ml
Vascular
cell
adhesion
molecule-1
overnight. After labelling cells
with 51Cr, an adhesion assay
was carried out as described in
Materials and Methods. (B)
After addition of 5-10µg/ml
LY294002,
cells
were
transferred onto Transwell
inserts and migration assay
was carried out. Data
represent three independent
experiments. p<0.05.
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experiments. Figure A) p<0.05
(significant), figure B) p<0.02.
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migration of these cells on fibronectin was reduced by 30% (p<0.05) in the presence of
10µg/ml LY294002 (Figure 3, panel B). The demonstration that LY294002 inhibited
specifically the migratory capacity of HMB2-α4 cells, and to a lesser extent DX3 cells, on
fibronectin substrates but not on other α4 substrates suggested that integrins other than α4β1
might be involved in this response. The refractory nature of VUP-α4 cells to this specific
inhibitor could also indicate that this cell type does not express the requisite integrin which
relies upon PI3-kinase activity. To address this possibility we examined patterns of integrin
expression on the small panel of melanoma cell lines shown in Table 1. The most obvious
difference between HMB2-α4 and DX3 cells on the one hand and the VUP-α4 cells on the
other, appeared to be the lack of expression of the αvβ3 heterodimer by VUP-α4 cells.
Therefore, VUP-αvβ3 transfected cell lines were used to determine the effect of αvβ3 integrin.
As shown in Figure 4, PI3-kinase inhibitor did not have any effect on melanoma cell migration,
even in the present of αvβ3 integrin. To evaluate which integrins regulated migration on the
fibronectin substrate, we performed a series of Transwell migration assays in the presence of
various anti-integrin antibodies. The results are shown in Figure 5. It can be seen (Figure 5,
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Figure 3.
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The level of integrins expression was investigated in melanoma cells by flow cytometer. The cells were
incubated with anti-integrin antibodies and then coupled with secondary antibody, FITC-RAM. After 30 min
incubation, cells were washed and fixed with 10% formaldehyde in PBSA. Cells were analysed with a flow
cytometer using Consort 30 software. “+” shows the level of integrin expression.
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Toxicity of LY294002 was determined by MTT assay for both VUP-α4 (Panel A) and HMB2-α4 (Panel B)
melanoma cells. Predetermined cell numbers were incubated with various concentrations of LY294002
during the experiment at 37ºC. Excess drug was washed off with 10% FCS and cells were plated out onto
96-well plates. After each day, 20µl of 5mg/ml MTT was added to each well and incubated for a further
2h. Medium was discarded and 200µl of DMSO was used to dissolve the dye. Density of dye was measured
by plate reader (ratio between OD of plates at 570nm). Results are the mean of quadruplicate wells.
Standard deviation less than 10%.
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panel A) that the majority of the migratory capacity in VUP cells was provided by α5, with
perhaps a minor component from an αv-containing heterodimer (VUP cells express αvβ1), and
that, broadly speaking, this pattern of activity was preserved in the VUP-α4 cells (Figure 5,
panel C). In contrast, the HMB2 cells appeared to depend for their migration on an interaction
between α5 and αv in that significant inhibition was achieved only in the combined presence of
antibodies to these two subunits (Figure 5, panel B). The pattern of behaviour was very
different in the HMB2-α4 cells. Now antibodies to αv, α5 and α3 were as effective in blocking
migration as were the combinations of αv+α5 antibodies (Figure 5, panel D). These results
appear to indicate that, in this cell line, de novo expression of α4, while not affecting the levels
of expression of other integrins, has an effect upon their functional capacity. The blocking
activity of LY294002 on the migratory capacity of cells of this sub-line may then be a reflection
of the involvement somehow of PI3-kinase in this process.

Discussion
Effects of PI3-kinase on α4β1-Mediated Melanoma Cell Adhesion and Migration
A few recent reports have suggested that PI3-kinase is required for integrin-mediated cell
migration and adhesion (24). In human melanoma cells, αvβ3-integrin-mediated cell adhesion
and migration on vitronectin was inhibited by a PI3-kinase inhibitior, suggesting a role for PI3kinase in the regulation of the affinity of αvβ3 integrin (28). PI3-kinase, acting on adhesion
and actin reorganisation in interleukin-8 induced neurophils, has been documented (28,30).
The stable association of PI3-kinase with FAK also was described in NIH 3T3 cells that were
stimulated by cell adhesion and PDGF in vivo and by autophosphorylation of recombinant FAK
in vitro.
The inhibition of PI3-kinase had no effect on the adhesion and migration of VUP-α4 cells
plated on fibronectin, CS1 or VCAM-1 (Figure 1). Both of these cellular functions were also
unaffected in HMB2-α4 (Figure 2) and DX3 (Figure 3) cells plated on either CS1 or VCAM-1,
indicating that α4β1-mediated cell adhesion and migration may not require the activation of
PI3-kinase in these two melanoma cell lines. However, the migration of HMB2-α4 and DX3
cells on fibronectin, but not their adhesion, was inhibited significantly by PI3-kinase inhibition.
These results suggest that different integrins, or possible different types of PI3-kinase, may
differentially regulate the migration of HMB2-α4 and DX3 cells rather than VUP-α4 cells. The
expression of the αvβ3 integrin was shown by FACS analysis to be lacking in VUP-α4 cells but
to be present in HMB2-α4 cells. Initially, therefore, it was thought that the αvβ3-mediated cell
migration in HMB2-α4 may require PI3-kinase activity. However, the inhibition of PI3-kinase
activity in VUP cells transfected with β3 cDNA did not have any effect on cell migration on
fibronectin suggesting that this was not the case (Figure 4). Interestingly, the expression of
different types of PI3-kinases in these two melanoma cell lines was observed such that clone o
of the (p110) catalytic subunit of PI3-kinase was expressed in HMB2-α4 cells but barely
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detected in VUP-α4 cells (Dr. B. Vanhaesbrook, personal communication). Experiments
involving the transfection of VUP cells with p110 cDNA may reveal whether this type of PI3kinase is responsible for the differences in migration of HMB2-α4 and VUP-aα4 cells on
fibronectin. On the other hand, the investigation of the involvement of different integrins in
fibronectin migration using inhibitory antibodies showed that in VUP-α4 cells, migration was
regulated mainly by α5β1, α4β1 and αvβ1, or the combination of these three integrins. In
HMB2-α4 cells, the integrins αv, α5 and α3 showed a significant regulatory function in cell
migration which was not evident in the parental cells, suggesting that transfection of HMB2α4 cells with a human α4 cDNA has a functional effect on other integrins. This may be one
explanation for the altered behaviour of HMB2-α4 cells in either adhesion or migration or it
may be that effects on these parameters require inhibition of various signal pathways.
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